Applera engages in the development of scientific & technical instruments for use by the biotechnology industry to research & develop pharmaceuticals. Having declined 21% over a 4-month period, stock price seems to have currently found support at the $32-level which served as support 6-months prior. Recent good buy-volume, and formation of a bullish-reversal Hammer candlestick, combined with oversold conditions may suggest a reversal in price action. Stop-loss close below $32.
No comments:
Post a Comment